Angiotensin ii utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake

Amy K.L. Banes-Berceli, Hind Al-Azawi, Daniel Proctor, Harvey Qu, Dominic Femminineo, Crystal Hill-Pyror, R. Clinton Webb, Michael W. Brands

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Janus kinase (JAK) 2 is activated by ANG II in vitro and in vivo, and chronic blockade of JAK2 by the JAK2 inhibitor AG-490 has been shown recently to attenuate ANG II hypertension in mice. In this study, AG-490 was infused intravenously in chronically instrumented rats to determine if the blunted hypertension was linked to attenuation of the renal actions of ANG II. In male Sprague-Dawley rats, after a control period, ANG II at 10 ng·kg -1·min -1 was infused intravenously with or without AG-490 at 10 ng·kg -1·min -1 iv for 11 days. ANG II infusion (18 h/day) increased mean arterial pressure from 91 ± 3 to 168 ± 7 mmHg by day 11. That response was attenuated significantly in the ANG II + AG-490 group, with mean arterial pressure increasing only from 92 ± 5 to 127 ± 3 mmHg. ANG II infusion markedly decreased urinary sodium excretion, caused a rapid and sustained decrease in glomerular filtration rate to ~60% of control, and increased renal JAK2 phosphorylation; all these responses were blocked by AG-490. However, chronic AG-490 treatment had no effect on the ability of a separate group of normal rats to maintain normal blood pressure when they were switched rapidly to a low-sodium diet, whereas blood pressure fell dramatically in losartan-treated rats on a low-sodium diet. These data suggest that activation of the JAK/STAT pathway is critical for the development of ANG II-induced hypertension by mediating its effects on renal sodium excretory capability, but the physiological control of blood pressure by ANG II with a low-salt diet does not require JAK2 activation.

Original languageEnglish (US)
Pages (from-to)R1169-R1176
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume301
Issue number4
DOIs
StatePublished - Oct 1 2011

Fingerprint

Janus Kinase 2
Angiotensins
Hypotension
Salts
Hypertension
Sodium-Restricted Diet
Blood Pressure
Kidney
Arterial Pressure
Sodium
Janus Kinases
Critical Pathways
Losartan
Glomerular Filtration Rate
Sprague Dawley Rats
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
Phosphorylation

Keywords

  • AG-490
  • Intracellular signaling
  • Losartan
  • Mean arterial pressure
  • Sodium- deficient diet

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Angiotensin ii utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake. / Banes-Berceli, Amy K.L.; Al-Azawi, Hind; Proctor, Daniel; Qu, Harvey; Femminineo, Dominic; Hill-Pyror, Crystal; Clinton Webb, R.; Brands, Michael W.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 301, No. 4, 01.10.2011, p. R1169-R1176.

Research output: Contribution to journalArticle

@article{fee980567853420b96568576445d6397,
title = "Angiotensin ii utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake",
abstract = "Janus kinase (JAK) 2 is activated by ANG II in vitro and in vivo, and chronic blockade of JAK2 by the JAK2 inhibitor AG-490 has been shown recently to attenuate ANG II hypertension in mice. In this study, AG-490 was infused intravenously in chronically instrumented rats to determine if the blunted hypertension was linked to attenuation of the renal actions of ANG II. In male Sprague-Dawley rats, after a control period, ANG II at 10 ng·kg -1·min -1 was infused intravenously with or without AG-490 at 10 ng·kg -1·min -1 iv for 11 days. ANG II infusion (18 h/day) increased mean arterial pressure from 91 ± 3 to 168 ± 7 mmHg by day 11. That response was attenuated significantly in the ANG II + AG-490 group, with mean arterial pressure increasing only from 92 ± 5 to 127 ± 3 mmHg. ANG II infusion markedly decreased urinary sodium excretion, caused a rapid and sustained decrease in glomerular filtration rate to ~60{\%} of control, and increased renal JAK2 phosphorylation; all these responses were blocked by AG-490. However, chronic AG-490 treatment had no effect on the ability of a separate group of normal rats to maintain normal blood pressure when they were switched rapidly to a low-sodium diet, whereas blood pressure fell dramatically in losartan-treated rats on a low-sodium diet. These data suggest that activation of the JAK/STAT pathway is critical for the development of ANG II-induced hypertension by mediating its effects on renal sodium excretory capability, but the physiological control of blood pressure by ANG II with a low-salt diet does not require JAK2 activation.",
keywords = "AG-490, Intracellular signaling, Losartan, Mean arterial pressure, Sodium- deficient diet",
author = "Banes-Berceli, {Amy K.L.} and Hind Al-Azawi and Daniel Proctor and Harvey Qu and Dominic Femminineo and Crystal Hill-Pyror and {Clinton Webb}, R. and Brands, {Michael W.}",
year = "2011",
month = "10",
day = "1",
doi = "10.1152/ajpregu.00071.2011",
language = "English (US)",
volume = "301",
pages = "R1169--R1176",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Angiotensin ii utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake

AU - Banes-Berceli, Amy K.L.

AU - Al-Azawi, Hind

AU - Proctor, Daniel

AU - Qu, Harvey

AU - Femminineo, Dominic

AU - Hill-Pyror, Crystal

AU - Clinton Webb, R.

AU - Brands, Michael W.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Janus kinase (JAK) 2 is activated by ANG II in vitro and in vivo, and chronic blockade of JAK2 by the JAK2 inhibitor AG-490 has been shown recently to attenuate ANG II hypertension in mice. In this study, AG-490 was infused intravenously in chronically instrumented rats to determine if the blunted hypertension was linked to attenuation of the renal actions of ANG II. In male Sprague-Dawley rats, after a control period, ANG II at 10 ng·kg -1·min -1 was infused intravenously with or without AG-490 at 10 ng·kg -1·min -1 iv for 11 days. ANG II infusion (18 h/day) increased mean arterial pressure from 91 ± 3 to 168 ± 7 mmHg by day 11. That response was attenuated significantly in the ANG II + AG-490 group, with mean arterial pressure increasing only from 92 ± 5 to 127 ± 3 mmHg. ANG II infusion markedly decreased urinary sodium excretion, caused a rapid and sustained decrease in glomerular filtration rate to ~60% of control, and increased renal JAK2 phosphorylation; all these responses were blocked by AG-490. However, chronic AG-490 treatment had no effect on the ability of a separate group of normal rats to maintain normal blood pressure when they were switched rapidly to a low-sodium diet, whereas blood pressure fell dramatically in losartan-treated rats on a low-sodium diet. These data suggest that activation of the JAK/STAT pathway is critical for the development of ANG II-induced hypertension by mediating its effects on renal sodium excretory capability, but the physiological control of blood pressure by ANG II with a low-salt diet does not require JAK2 activation.

AB - Janus kinase (JAK) 2 is activated by ANG II in vitro and in vivo, and chronic blockade of JAK2 by the JAK2 inhibitor AG-490 has been shown recently to attenuate ANG II hypertension in mice. In this study, AG-490 was infused intravenously in chronically instrumented rats to determine if the blunted hypertension was linked to attenuation of the renal actions of ANG II. In male Sprague-Dawley rats, after a control period, ANG II at 10 ng·kg -1·min -1 was infused intravenously with or without AG-490 at 10 ng·kg -1·min -1 iv for 11 days. ANG II infusion (18 h/day) increased mean arterial pressure from 91 ± 3 to 168 ± 7 mmHg by day 11. That response was attenuated significantly in the ANG II + AG-490 group, with mean arterial pressure increasing only from 92 ± 5 to 127 ± 3 mmHg. ANG II infusion markedly decreased urinary sodium excretion, caused a rapid and sustained decrease in glomerular filtration rate to ~60% of control, and increased renal JAK2 phosphorylation; all these responses were blocked by AG-490. However, chronic AG-490 treatment had no effect on the ability of a separate group of normal rats to maintain normal blood pressure when they were switched rapidly to a low-sodium diet, whereas blood pressure fell dramatically in losartan-treated rats on a low-sodium diet. These data suggest that activation of the JAK/STAT pathway is critical for the development of ANG II-induced hypertension by mediating its effects on renal sodium excretory capability, but the physiological control of blood pressure by ANG II with a low-salt diet does not require JAK2 activation.

KW - AG-490

KW - Intracellular signaling

KW - Losartan

KW - Mean arterial pressure

KW - Sodium- deficient diet

UR - http://www.scopus.com/inward/record.url?scp=80053624731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053624731&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.00071.2011

DO - 10.1152/ajpregu.00071.2011

M3 - Article

C2 - 21813872

AN - SCOPUS:80053624731

VL - 301

SP - R1169-R1176

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4

ER -